Clinuvel Pharmaceuticals Limited
CLVLY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $224 | $17 | $184 | $39 |
| Short-Term Investments | $0 | $181 | $0 | $136 |
| Receivables | $27 | $16 | $26 | $13 |
| Inventory | $9 | $9 | $11 | $13 |
| Other Curr. Assets | $3 | $4 | $1 | $1 |
| Total Curr. Assets | $263 | $228 | $222 | $201 |
| Property Plant & Equip (Net) | $7 | $7 | $8 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $1 | $0 | $0 | $2 |
| Other NC Assets | $0 | $1 | $1 | $0 |
| Total NC Assets | $9 | $9 | $9 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $272 | $236 | $231 | $212 |
| Liabilities | – | – | – | – |
| Payables | $3 | $6 | $2 | $6 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $16 | $21 |
| Deferred Revenue | $0 | $0 | $0 | $21 |
| Other Curr. Liab. | $24 | $7 | $7 | -$19 |
| Total Curr. Liab. | $27 | $13 | $25 | $29 |
| LT Debt | $0 | $0 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $0 | $0 | $3 |
| Other NC Liab. | $0 | $5 | $2 | $3 |
| Total NC Liab. | $4 | $6 | $3 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $31 | $19 | $28 | $33 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $169 | $169 | $169 | $170 |
| Retained Earnings | $64 | $42 | $30 | $5 |
| AOCI | $8 | $7 | $4 | $4 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $241 | $217 | $203 | $179 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $272 | $236 | $231 | $212 |
| Net Debt | -$224 | -$16 | -$183 | -$38 |